Latest News

YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

GAITHERSBURG, Md., July 21, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-07-22 04:30 5059

YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023

GAITHERSBURG, Md., July 22, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-07-22 04:30 4023

Mabwell Announces the NMPA Approval of Novel B7-H3 ADC (7MW3711) for IND

SHANGHAI, July 21, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of 7MW3711 for advanced malignant solid tumor was approved by the National Medical Products Administration (NMPA). 7MW3711...

2023-07-22 00:00 5452

CASETiFY Expands Its Customization Studio with Updated Fonts, Texts, and Color Options

New ways to personalize CASETiFY's most popular accessories, designed by you. LOS ANGELES, July 21, 2023 /PRNewswire/ -- Today, global lifestyle tech accessory brand CASETiFY announced updates to their ever-popular Customization Studio, giving customers additional options for personalizing their ...

2023-07-21 23:57 4783

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * If approved by the European Commission, ORSERDU would be the first an...

2023-07-21 23:44 7089

SunHo Announces First Patient Dosed in Phase I/II Clinical Trial of a Potential First-in-class Immunocytokine IBB0979

NANJING, China, July 21, 2023 /PRNewswire/ -- SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharmaceutical company in immunocytokines with full-set of capabilities from discovery to commercialization, announced that IBB0979 (B7H3-IL10 immunocytokine), a potential first...

2023-07-21 22:51 3600

LILYSILK Launches Its Gorgeous 2023 Fall Collection, The Art of Living

NEW YORK, July 21, 2023 /PRNewswire/ -- LILYSILK, the world's leading silk brand with a mission to inspire people to live spectacular, sustainable lives, is launching its 2023 Fall Collection, themedThe Art of Living

2023-07-21 22:00 4244

Caravelle International Group Granted Extension by Nasdaq to Regain Compliance with Filing Requirements

SINGAPORE, July 21, 2023 /PRNewswire/ -- Caravelle International Group (Nasdaq: CACO), a global ocean technology company, today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), granting the Company an extension to regain compliance with Nasdaq's filing requirem...

2023-07-21 21:45 5045

Smart HDMI Sync Box for high-end user, Lumary launches the Imvisual HDMI Sync Kit series

LOS ANGELES, July 21, 2023 /PRNewswire/ -- Lumary, a company at the forefront of innovation in the smart lighting industry, proudly announces the launch of the Lumary Imvisual HDMI Sync Kit series, which is based on HDMI synchronization box technology. This kit boasts outstanding features and a ...

2023-07-21 21:03 4353

LG Innotek published the 2022-2023 Sustainability Report

* Achieved 20% carbon neutrality within one year after the declaration and increased shareholder-friendly policies such as the 10% dividend payout ratio * Increased investment in R&D by 33% from the previous year to strengthen the competitiveness of future business SEOUL, South Korea, July 21,...

2023-07-21 21:00 5093

TUMI AND HIGHSNOBIETY JOIN FORCES ON DISRUPTIVE CONTENT SERIES, BRINGING THE TUMI | McLAREN COLLECTION TO THREE FORMULA 1 GRAND PRIX RACES ACROSS THREE CONTINENTS

Captured through the lens of Highsnobiety, this three-part series entitled 'The High Road' will chronicle a journey in McLaren's supercars through Britain, Singapore, and Las Vegas, and bring to life three unique stories with unexpected talent and eye-catching visuals.  NEW YORK, July 21, 2023 /...

2023-07-21 21:00 6628

CBAK Energy Expands Battery Production Capacities through Strategic Collaborations in Shangqiu City, Henan, China

* Meeting Surging Demand for Lithium-ion Batteries with Cost-Effective Expansion DALIAN, China, July 21, 2023 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company"), a leading lithium-ion battery manufacturer and electric energy solution provider inChina,...

2023-07-21 20:30 8887

WiMi Developed an HMD-based Control System for Humanoid Robots Controlled by BCI

BEIJING, July 21, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced its development of a humanoid robot control system based on a head-mounted display (HMD) controlled by ...

2023-07-21 20:00 5043

Delta Wins the "2023 Best Companies to Work For in Asia Award" by HR Asia with its DEI and Digital Transformation Highly Recognized

TAIPEI, July 21, 2023 /PRNewswire/ -- Delta, a global leading provider of power and thermal management solutions, today announced it has been selected as one of the "Best Companies to Work For inAsia" for the second time by HR Asia, the prominent magazine inAsia on human resources. In the evaluat...

2023-07-21 19:47 4361

Commercial successes of product debuts a growing trend at the CIIE

SHANGHAI, July 21, 2023 /PRNewswire/ -- For five consecutive years the China International Import Expo (CIIE) inShanghai has celebrated its status as the first national expo themed on imports, creating an ever-growing number of beneficial spillovers – including transforming exhibited items into p...

2023-07-21 19:05 4612

Autoliv: Financial Report April - June 2023

STOCKHOLM, July 21, 2023 /PRNewswire/ -- (NYSE: ALV) (SSE: ALIV.sdb) Q2 2023: Record second quarter sales Financial highlights Q2 2023 $2,635 million net sales  27% net sales increase 27% organic sales increase* 3.6% operating margin 8.0% adjusted operating margin* $0.61 EPS, 32% decrease $1.93 ad...

2023-07-21 18:56 8698

134th Canton Fair New Highlights: Optimization and Adjustment of Exhibition Sections

GUANGZHOU, China, July 21, 2023 /PRNewswire/ -- The 134th China Import and Export Fair ("Canton Fair" or "the Fair") is scheduled to be held both onsite and online in a merged format onOctober 15, boasting new highlights and features with optimized exhibition sections that adapted to global marke...

2023-07-21 18:53 9740

Prodigy Finance Establishes another $350 Million Facility for International Masters Students with Citi, Schroders Capital, and SCIO Capital

LONDON, July 21, 2023 /PRNewswire/ -- Prodigy Finance, a social impact driven FinTech and a leading international student loan lender, is proud to announce a$350 million facility with Citi, Schroders Capital and SCIO Capital. This is the first transaction that Prodigy has closed under their new ...

2023-07-21 18:51 3757

Accor accelerates in Japan with agreement to operate 23 properties

ACCOR SIGNS MILESTONE AGREEMENT WITH EBISU RESORT LLC, WITH 23 PROPERTIES SET TO JOIN THE GROUP'S HOTEL NETWORK BY Q2 2024 PARIS, July 21, 2023 /PRNewswire/ -- Accor's presence in Japan is set to double while hotel openings gain momentum throughout the region. With travel and tourism surging onc...

2023-07-21 18:34 3503

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...

2023-07-21 18:00 4363